1. Statin Selection in Special Patient Populations: A Case Challenge

2. Goals

3. Multiple Challenges in Statin Selection

4. Case 1: Lipid Clinic Referral James Smith, 51 Years Old

5. Case 1: Lipid Clinic Referral (cont)

6. Understanding the Changing CV Risk Burden in HIV infection

7. Reasons for Increased ASCVD Risk in HIV Infection

8. Assessment of CV Risk in Primary Prevention for an HIV-Infected Patient

9. Match Lipid Treatment to Level of Risk Per NLA, Count Risk Factors, Add HIV as Additional Factor

10. Use of Statins With PIs

11. INTREPID Safety-Efficacy Trial

12. REPRIEVE CV Outcomes Trial

13. Statin-Associated Myopathy: Risk Factors and Cytochrome P450 Associations

14. Case 2: Statin Intolerance Sue Jones; 63 Year Old

15. What Are SAMS?

16. Spectrum of SAMS: NLA Statin Safety Task Force

17. SAMS Impact on Statin Therapy

18. Nocebo Effect

19. NLA Statin Myalgia Clinical Index Score

20. How to Manage Statin Intolerance and Recognize Risk Factors

21. Thoughtful Statin Selection

22. Abbreviations

23. Abbreviations (cont)